HEL •
Healthcare •
Drug Manufacturers - General •
Quote as of 08/07/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeHEL
Market Capitalization11,199 mln
Float123 mln
Earnings Date10/28/2026
EPS
4.18
Solid
P / E
19.47
Moderately valued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-1.41
Manipulation likely
Relative Strength
65
/ 100
Outperforming
Debt / Equity
0.29
Very low leverage
Business Description
Founded in Finland over a century ago, Orion Oyj is a pharmaceutical company that researches, produces, and sells a broad range of medicines for both people and animals across Europe, North America, and beyond. Its human health portfolio covers serious conditions such as prostate cancer, Parkinson's disease, heart failure, and respiratory illnesses like asthma and COPD, while its animal health range supports veterinary care worldwide. The company also manufactures active pharmaceutical ingredients, provides contract production services, and sells consumer health products including vitamins, skincare, and over-the-counter medicines. Orion works with partners such as Bayer and Tenax Therapeutics to bring new treatments to market.